Grace Therapeutics (GRCE) Non Operating Income (2019 - 2026)
Grace Therapeutics' Non Operating Income was $127,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$272,000 a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Non Operating Income (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Non Operating Income was $1.98 million through Jun 30, 2026, down 1.8% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.58 million, down 59.5% from FY2025.
- In earlier fiscal years, Non Operating Income was $3.91 million in FY2025, -$1.83 million in FY2024, $184,000 in FY2023 (-96.4%) and $5.12 million in FY2022.
- Quarterly Non Operating Income has moved between -$1.63 million (fiscal Q2 2024) and $4.55 million (fiscal Q2 2022) over five years.
- Per Business Quant data, GRCE's Non Operating Income in the three fiscal quarters before Q1 2027 was $132,000 (Q4 2026), $134,000 (Q3 2026) and $1.59 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | - |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | - |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | - |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 127,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | 134,000.00 |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | -272,000.00 |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | -1.06 Mn |
| Sep 30, 2024 | 547,000.00 |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | -792,000.00 |
| Dec 31, 2023 | 444,000.00 |
| Sep 30, 2023 | -1.63 Mn |
| Jun 30, 2023 | 142,000.00 |
| Mar 31, 2023 | 115,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Mar 31, 2022 | -149,000.00 |
| Dec 31, 2021 | 696,000.00 |
| Sep 30, 2021 | 4.55 Mn |
API Access
Grace Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();